Summary
The Novel Antiplatelet Therapy in Patients Undergoing Nonurgent Percutaneous Coronary Interventions [INNOVATE PCI] trial compared with clopidogrel and elinogrel for platelet inhibition without increasing bleeding risk in patients who were undergoing elective percutaneous coronary intervention.
- Coronary Artery Disease
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- Thrombotic Disorders
- © 2010 MD Conference Express